The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


ZANTAC



PCO ManufacturingPPA0465/033/002

Main Information

Trade NameZANTAC
Active SubstancesRANITIDINE HYDROCHLORIDE
Dosage FormFilm Coated Tablet
Licence HolderPCO Manufacturing
Licence NumberPPA0465/033/002

Group Information

ATC CodeA02BA02 ranitidine

Status

License statusWithdrawn
Withdrawn Date31/12/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back